Revision of the International Neuroblastoma Pathology Classification: Confirmation of Favorable and Unfavorable Prognostic Subsets in Ganglioneuroblastoma, Nodular

Cancer

Volumn 98, Issue 10, 2003, Pages 2274-2281

  Peuchmaur, Michel ^a   D'Amore, Emanuele S G ^b   Joshi, Vijay V ^c   Hata, Jun Ichi ^d   Roald, Borghild ^e   Dehner, Louis P ^f   Gerbing, Robert B ^g   Stram, Daniel O ^g   Lukens, John N ^h   Matthay, Katherine K ⁱ   Shimada, Hiroyuki ^j  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b SAN BORTOLO HOSPITAL   (Italy)

^c HARTFORD HOSPITAL   (United States)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e UNIVERSITY OF OSLO   (Norway)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Children's Oncol Grp Oper Ctr   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SAN FRANCISCO   (United States)

^j CHILDREN S HOSPITAL LOS ANGELES   (United States)

more..

Author keywords

Ganglioneuroblastoma, nodular; Histology; International classification; International Neuroblastoma Pathology Committee; Peripheral neuroblastic tumors; Prognostic subsets

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CHILD; CHILD, PRESCHOOL; FEMALE; GANGLIONEUROBLASTOMA; HUMANS; INFANT; MALE; NEOPLASM STAGING; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0242611572     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11773     Document Type: Review

References (16)

1. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors. Recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999;86:349-363.
2. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV. Roald B, et al. The International Neuroblastoma Pathology Classification (the Shimada System). Cancer. 1999;86:364-372.
3. Joshi VV. Peripheral neuroblastic tumors: pathologic classification based on recommendations of International Neuroblastoma Pathology Committee (modification of Shimada classification). Pediatr Dev Pathol. 2000;3:184-189.
4. Shimada H, Chatten J, Newton WA, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984;73:405-416.
5. Joshi VV, Cantor AB, Altshuler G, et al. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. Cancer. 1992;69:2183-2196.
6. Shimada H, Umehara S, Monobe Y, et al. International Neuroblastoma Pathology Classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer. 2001;92:2451-2461.
7. Umehara S, Nakagawa A, Matthay KK, et al. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular. Cancer. 2000;89:1150-1161.
8. Matthay KK, Perez C, Seeger RC, et al. Successful treatment of Stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group Study. J Clin Oncol. 1998;16:1256-1264.
9. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999;341:1165-1173.
10. Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of Stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol. 2000;18:477-486.
11. Perez CA, Matthay KK, Atkinson JB, et al. Biologic variables in the outcome of Stage I and II neuroblastoma treated with surgery as primary therapy: a Children's Cancer Group study. J Clin Oncol. 2000;18:18-26.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457-481.
13. Stout AP. Ganglioneuroma of the sympathetic nervous system. Surg Gynecol Obstet. 1947;84:101-110.
14. Joshi VV, Cantor AB, Altshuler G, et al. Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group. Arch Pathol Lab Med. 1996;120:859-865.
15. Adam A, Hochholzer L. Ganglioneuroblastoma of the posterior mediastinum: a clinicopathologic review of 80 cases. Cancer. 1981;47:373-381.
16. Schmidt ML, Salwen HR, Chagnovich D, Bauer KD, Crawford SE, Cohn SL. Evidence for molecular heterogeneity in human ganglioneuroblastoma. Pediatr Pathol. 1993;13:787-796.